1922 Bull. Chem. Soc. Jpn. Vol. 79, No. 12 (2006)
1,5,3,7-Dichalcogenadiazocanes
(98 mg, 0.55 mmol) was added dropwise to a dichloromethane
solution (100 mL) of 1,5,3,7-ditelluradiazocane 3 (0.50 mmol) at
ꢁ78 ꢂC under an argon atmosphere, and the reaction mixture was
stirred at ꢁ78 ꢂC for 30 min. The reaction was quenched with an
excess amount of 10% aqueous NaOH solution, and was extracted
with dichloromethane. The organic layer was washed with water
and was dried over anhydrous Na2SO4 powder. After removing
the solvent in vacuo, the residual crude mixture, containing 1,2,4-
ditellurazolidine 6 and succinimide 7, was subjected to recrystal-
lization from dichloromethane–hexane gave pure 1,2,4-ditellura-
zolidine 6 as brownish green solids. The filtrate was subjected
to chromatographic purification using silica gel and the subse-
quent recrystallization from hexane–dichloromethane to afford
succinimide 7.
General Procedure for Aerobic Oxidation of 1,5,3,7-Ditel-
luradiazocanes (3). A dichloromethane solution (150 mL) of
1,5,3,7-ditelluradiazocane 3 (0.80 mmol) was stirred in air at room
temperature for 3 h. The reaction was then filtrated to remove the
precipitated elemental tellurium. After removing the solvent of
the filtrate in vacuo, the residual crude mixture was subjected to
recrystallization to give 1,2,4-ditellurazolidine 6 as brownish
green solids.
bon tetrachloride solution (20 mL) of bromine (Br2, 196 mg,
1.10 mmol) was added dropwise to a dichloromethane solution
(130 mL) of 1,5,3,7-dithiadiazocane 1 (1.50 mmol) and elemental
sulfur (144 mg, 0.56 mmol) at ꢁ78 ꢂC under an argon atmosphere,
and the reaction mixture was stirred at ꢁ78 ꢂC for 10–60 min. The
reaction was quenched with an excess amount of 10% aqueous
NaOH solution, and was extracted with dichloromethane. The
organic layer was washed with water and was dried over an-
hydrous sodium sulfate powder. After removing the solvent
in vacuo, the residual yellow solid was subjected to chromato-
graphic purification using silica gel to obtain 1,2,3,4,5,7-penta-
thiazocane 9 and perhydro-1,3,5-thiadiazine 8. Recrystallization
from ethanol gave pure 1,2,3,4,5,7-pentathiazocane 9 as pale yel-
low solids.
9a (R ¼ C6H5): Pale yellow needles, mp 123.0–124.0 ꢂC
(dec.); MS (m=z) 247 (Mþ ꢁ S; 4%), 215 (Mþ ꢁ S2; 5%), 183
(Mþ ꢁ S3; 68%), 119 (Mþ ꢁ S5; 80%), 91 (bp); IR (KBr) 3060,
3039, 3029, 1596, 1503, 1440, 1365, 1347, 1270, 1238 cmꢁ1
;
1H NMR (CDCl3) ꢁ 4.79 (2H, d, J ¼ 15:0 Hz), 5.70 (2H, d, J ¼
15:0 Hz), 6.60–7.50 (5H, m); 13C NMR (CDCl3) ꢁ 65.9 (dd),
113.8 (d), 120.5 (d), 129.9 (d), 141.9 (s). Calcd for C8H9NS5:
C, 34.38; H, 3.25; N, 5.10; S, 57.37%. Found: C, 34.33; H,
3.15; N, 5.03; S, 56.93%.
6a (R ¼ C6H5): Brownish green crystals, mp 104.0–104.5 ꢂC
(dec.); MS (m=z) 379 (Mþ; 9%, 130Te), 119 (Mþ ꢁ Te2; bp); IR
(KBr) 3045, 2962, 1597, 1498, 1371, 1249, 1132, 1002, 753, 682
9b (R ¼ p-ClC6H4): Pale yellow needles, mp 128.7–129.5
ꢂC; MS (m=z) 313 (Mþ; 4%), 281 (Mþ ꢁ S; 1%), 250 (Mþ ꢁ S2;
6%), 217 (Mþ ꢁ S3; 21%), 64 (S2; bp); IR (KBr) 2930, 2366,
cmꢁ1 1H NMR (CDCl3) ꢁ 5.37 (4H, br s), 6.90–7.50 (5H, m);
;
13C NMR (CDCl3) ꢁ 36.6 (t), 118.1 (d), 125.0 (d), 129.3 (d), 144.9
(s). Calcd for C8H9NTe2: C, 25.67; H, 2.40; N, 3.74%. Found: C,
25.17; H, 2.40; N, 3.51%.
1863, 1597, 1495, 1441, 1370, 1326, 1268, 1238, 890, 806 cmꢁ1
;
1H NMR (CDCl3) ꢁ 4.79 (2H, d, J ¼ 15:0 Hz), 5.62 (2H, d, J ¼
15:0 Hz), 6.67 (2H, d, J ¼ 9:0 Hz), 7.30 (2H, d, J ¼ 9:0 Hz);
13C NMR (CDCl3) ꢁ 65.6 (d), 114.9 (d), 125.8 (d), 129.7 (d),
140.4 (s). Calcd for C8H8ClNS5: C, 30.61; H, 2.57; N, 4.40%.
Found: C, 30.53; H, 2.65; N, 4.40%.
6b (R ¼ p-ClC6H4): Metallic green powder, mp 134.0–135.0
ꢂC (dec.); MS (m=z) 412 (Mþ; 4%, 130Te, 35Cl), 153 (Mþ ꢁ Te2;
bp); IR (KBr) 3088, 3069, 3054, 2972, 1589, 1493, 1457, 1440,
1360, 1312, 1243, 1165, 1131, 1092, 991, 863, 817, 791, 769
9c (R ¼ p-CH3OC6H4):
Pale yellow needles, mp 91.2–
1
cmꢁ1; H NMR (CDCl3) ꢁ 5.30 (4H, br s), 7.11 (2H, d, J ¼ 8:9
91.8 ꢂC (dec.); MS (m=z) 277 (Mþ ꢁ S; 0.2%), 245 (Mþ ꢁ S2;
2%), 213 (Mþ ꢁ S3; 68%), 135 (Mþ ꢁ S5; 90%), 64 (S2; bp); IR
(KBr) 3047, 2992, 2948, 2920, 2827, 1578, 1511, 1436, 1364,
Hz), 7.27 (2H, d, J ¼ 8:9 Hz). Calcd for C8H8ClNTe2: C, 23.50;
H, 1.97; N, 3.43%. Found: C, 23.35; H, 1.82; N, 3.06%.
6c (R ¼ p-CH3OC6H4): Metallic green plates, mp 111.0–
111.5 ꢂC (dec.); MS (m=z) 409 (Mþ; 0.9%, 130Te), 149 (Mþ ꢁ
Te2; bp); IR (KBr) 3044, 2952, 2932, 1611, 1510, 1470, 1392,
1247, 1182, 1127, 1036, 821 cmꢁ1; 1H NMR (CDCl3) ꢁ 3.76 (3H,
s), 5.32 (4H, br s), 6.84 (2H, d, J ¼ 9:1 Hz), 7.12 (2H, d, J ¼ 9:1
Hz); 13C NMR (CDCl3) ꢁ 38.5 (t), 55.4 (q), 114.5 (d), 119.7 (d),
137.4 (s), 157.3 (s). Calcd for C9H11NOTe2: C, 26.73; H, 2.74;
N, 3.46%. Found: C, 26.66; H, 2.74; N, 3.58%.
1274, 1249, 1207, 1186, 1143, 1045 cmꢁ1 1H NMR (CDCl3) ꢁ
;
3.78 (3H, s), 4.79 (2H, d, J ¼ 15:0 Hz), 5.66 (2H, d, J ¼ 15:0 Hz),
6.74 (2H, d, J ¼ 9:1 Hz), 6.92 (2H, d, J ¼ 9:1 Hz); 13C NMR
(CDCl3) ꢁ 55.6 (q), 66.7 (d), 115.4 (d), 136.0 (d), 154.2 (s). Calcd
for C9H11NOS5: C, 34.93; H, 3.58; N, 4.53%. Found: C, 35.21; H,
3.57; N, 4.40%.
9d (R ¼ p-CH3C6H4): Pale yellow needles, mp 135.0–136.0
ꢂC (dec.); MS (m=z) 293 (Mþ; 0.1%), 261 (Mþ ꢁ S; 0.1%), 229
(Mþ ꢁ S2; 15%), 197 (Mþ ꢁ S3; 39%), 133 (Mþ ꢁ S5; 45%), 105
(bp), 64 (S2; 66); IR (KBr) 2917, 2852, 1616, 1577, 1519, 1441,
6d (R ¼ p-CH3C6H4): Metallic green needles, mp 111.0–
112.0 ꢂC (dec.); MS (m=z) 393 (Mþ; 2%, 130Te), 133 (Mþ ꢁ Te2;
bp); IR (KBr) 2920, 1516, 1364, 1237, 1166, 1127, 991, 799
1367, 1267, 1235, 1206, 1195, 1152, 1032, 890 cmꢁ1 1H NMR
;
cmꢁ1
;
1H NMR (CDCl3) ꢁ 2.29 (3H, s), 5.34 (4H, br s), 7.05–
(CDCl3) ꢁ 2.29 (3H, s), 4.78 (2H, d, J ¼ 15:0 Hz), 5.68 (2H, d,
J ¼ 15:0 Hz), 6.69 (2H, d, J ¼ 8:3 Hz), 7.15 (2H, d, J ¼ 8:3 Hz);
13C NMR (CDCl3) ꢁ 20.2 (q), 66.1 (dd), 113.8 (d), 130.0 (d),
130.2 (d), 130.6 (s). Calcd for C9H11NS5: C, 36.83; H, 3.78; N,
4.77%. Found: C, 36.80; H, 3.76, N, 4.60%.
7.12 (4H, m); 13C NMR (CDCl3) ꢁ 20.8 (q), 37.4 (t), 117.9 (d),
129.9 (d), 134.8 (s), 141.4 (s). Calcd for C9H11NTe2: C, 27.83;
H, 2.85; N, 3.61%. Found: C, 27.35; H, 2.68; N, 3.43%.
6e (R ¼ p-FC6H4): Metallic dark green plates, mp 143.0–
144.0 ꢂC (dec.); MS (m=z) 397 (Mþ; 99%, 130Te), 260 (Te2; bp),
138 (Mþ ꢁ Te2; 69%), 110 (FC6H4N; 90%); IR (KBr) 3068,
10a (R ¼ C6H5): Colorless prisms, mp 103.0–105.0 ꢂC (lit.88
105 ꢂC); IR (KBr) 3025, 2918, 1600, 1579, 1497, 1446, 1351
3049, 1501, 1359, 1229, 1158, 1135, 1108, 1052, 990 cmꢁ1
;
cmꢁ1; H NMR (CDCl3) ꢁ 4.93 (4H, s), 5.17 (2H, s), 6.78–7.15
1
1H NMR (DMSO-d6) ꢁ 5.45 (4H, br s), 7.12–7.27 (4H, m);
13C NMR (DMSO-d6) ꢁ 38.2 (t), 115.6 (dd, JC{F ¼ 21:9 Hz,
JC{H ¼ 21:7 Hz), 119.4 (dd, JC{F ¼ 8:2 Hz, JC{H ¼ 4:0 Hz), 139.5
(s), 158.9 (d, JC{F ¼ 240:0 Hz). Calcd for C8H8FNTe2: C, 24.49;
H, 2.06; N, 3.57%. Found: C, 24.30; H, 2.34; N, 3.63%.
(10H, m).
10b (R ¼ p-ClC6H4): Colorless prisms, mp 149.7–150.6 ꢂC;
MS (m=z) 324 (Mþ; 11%), 185 (Mþ ꢁ CH2=NC6H4Cl; 32%),
139 (CH2=NC6H4Cl; bp), 111 (C6H4Cl; 31%); IR (KBr) 2927,
1600, 1589, 1492, 1234, 940, 562 cmꢁ1; 1H NMR (CDCl3) ꢁ 4.88
(4H, s), 5.11 (2H, s), 6.88 (4H, d, J ¼ 9:0 Hz), 7.08 (4H, d, J ¼
9:0 Hz); 13C NMR (CDCl3) ꢁ 55.8 (s), 69.9 (s), 119.1 (d), 125.8
General Procedure for Oxidation of 1,5,3,7-Dithiadiazocane
(1) Using Bromine in the Presence of Elemental Sulfur. A car-